Edition:
United States

Oncopeptides AB (ONCO.ST)

ONCO.ST on Stockholm Stock Exchange

80.30SEK
7:15am EST
Change (% chg)

0.30kr (+0.38%)
Prev Close
80.00kr
Open
80.00kr
Day's High
81.20kr
Day's Low
79.70kr
Volume
2,951
Avg. Vol
45,134
52-wk High
96.00kr
52-wk Low
41.10kr

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Alan Hulme

66 2010 Chairman of the Board

Jakob Lindberg

45 2011 Chief Executive Officer

Birgitta Stahl

46 2016 Chief Financial Officer

Eva Nordstrom

47 2012 Vice President, Head of Clinical Development

Paula Boultbee

59 2016 Chief Commercial Officer